Progress being made toward Mo-99 production at Darlington

September 29, 2020, 12:25PMNuclear News

Darlington nuclear generating station. Photo: OPG

Ontario Power Generation, its subsidiary Laurentis Energy Partners, and BWXT ITG Canada and its affiliates announced on September 24 that the companies are making “significant progress” toward the production of molybdenum-99 at OPG’s Darlington nuclear power plant. Darlington will become the first commercial operating nuclear reactor to produce the medical radioisotope.

A precursor to technetium-99m, Mo-99 is used in more than 40 million procedures a year to detect cancers and diagnose various medical conditions.

To continue reading, log in or create a free account!

Related Articles

BWXT Canada awarded major contracts for 2 OPG plants

Work will support Pickering life extension and Darlington SMRs

January 29, 2025, 9:30AMNuclear News

Ontario Power Generation announced this week new contracts with BWXT Canada worth more than C$1 billion ($695.4 million) for projects at the Pickering and Darlington nuclear power plants....